All News Femasys Inc.

Equities

FEMY

US31447E1055

Market Closed - Nasdaq Other stock markets 01:30:00 17/05/2024 am IST			5-day change	1st Jan Change
1.29 ^USD	-3.01%		+1.57%	+32.31%

09/05	Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
09/05	Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council	06:00pm	GL
Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	09/05	MT
Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update	09/05	GL
Femasys Expands Commercial Management Team with Addition of Experienced New Hires	07/05	GL
Femasys Expands Commercial Management Team with Addition of Experienced New Hires	07/05	AQ
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare Initiatives	19/04	AQ
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives	18/04	GL
HC Wainwright Adjusts Femasys' Price Target to $12 From $10, Reiterates Buy Rating	01/04	MT
Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update	29/03	GL
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update	29/03	AQ
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed for the Treatment of Infertility	21/03	AQ
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape	21/03	GL
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility	20/03	GL
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility	20/03	AQ
Femasys Inc. Announces Positive Topline Data from Pivotal Trial for Its Fda-Cleared Femaseed®? for the Treatment of Infertility	20/03	CI
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024	13/03	GL
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	06/03	GL
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	06/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Femasys Inc.

Equities

FEMY

US31447E1055

All News

Filters